Buyers lifting price on the back of a positive report

New Buy Entry Alert PNV

Time Frame : Daily/Weekly

Sector : Health Care Equipment and Services

Key Stats : $1.05 Billion Market Cap, VWAP 1.60, ASX Ranking 236, 4 Week Av Turnover $3,851,994, Current Turnover (Intraday as at time of alert) $1,837,811.

Company Overview : Polynovo Limited (PNV, formerly Calzada Limited) is an Australian based medical device company that designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Their development program covers Breast Sling, Hernia, and Orthopedic applications.

Broker Consensus : BUY

PNV – Polynovo Limited

PNV came out with some very good results today to show growth in sales and earnings which saw buyers lift price higher. We expect to see some flow on effect in the coming days as longer term buyers process the news and expect the company to be cash flow positive in 2-3 years. Add to that the expected regulatory approval in the EU in the near future, we expect to see price supported. Happy to buy at 1.675 with a Stop Loss at 1.45. If price falls below 1.45 prior to entry, we will cancel the alert and re-assess the action.

Stock Code : PNV – Polynovo Limited

Company Website :

Current Price : 1.635

New Potential Buy Entry (Trigger Level) : 1.675

Potential Sell Exit Zone (Stop Loss) : 1.45

Status : On watch for Buy Entry Trigger